How pharma companies can build mutually beneficial relationships with biotech and digital health start-ups Seemingly every week, headlines declare new partnerships inked between global pharma ...

Over the last few years, more and more pharma companies have been talking about “direct to patient” or D2P approaches. In some ways, pharma connecting directly with patients isn’t novel at ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug powerhouse and has become one of the world’s most successful female ...

Ionis Pharmaceuticals (NASDAQ: IONS), a pharma company engaged in discovering and developing RNA-targeted therapeutics, has seen its stock decline by about 11% over the last week, trading at ...